Carotid intima-media thickness in HIV patients treated with antiretroviral therapy

Clinical Physiology and Functional Imaging

Volumn 27, Issue 3, 2007, Pages 173-179

  Lebech, Anne Mette ^a   Wiinberg, Niels ^b   Kristoffersen, Ulrik Sloth ^c   Hesse, Birger ^c   Petersen, Claus Leth ^b   Gerstoft, Jan ^c   Kjær, Andreas ^c,d  

^a HVIDOVRE HOSPITAL   (Denmark)

^b FREDERIKSBERG HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antiretroviral therapy; Atherosclerosis; Cholesterol; HIV; Lipids

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; CHOLESTEROL; DIDANOSINE; EFAVIRENZ; HIGH DENSITY LIPOPROTEIN; INDINAVIR; LAMIVUDINE; LOPINAVIR; LOW DENSITY LIPOPROTEIN; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADULT; ARTERIOSCLEROSIS; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DYSLIPIDEMIA; ECHOGRAPHY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; PRIORITY JOURNAL; SMOKING;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CAROTID ARTERY DISEASES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 34247208674     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2007.00737.x     Document Type: Article

References (29)

1. Bozzette SA, Ake CF, Tam HK, Chang SW, Louis TA. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med (2003); 348: 702-710.
2. Brousseau ME, Schaefer EJ, Wolfe ML, Bloedon LT, Digenio AG, Clark RW, Mancuso JP, Rader DJ. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. N Engl J Med (2004); 350: 1505-1515.
3. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS (1998); 12: F51-F58.
4. Chironi G, Escaut T, Gariepy J, Cogny A, Monsuez TJ, Levenson J, Simon A, Vittecoq D. Carotid intima-media thickness in heavily pretreated HIV-infected patients. JAIDS - Journal of Acquired Immune Deficiency Syndromes (2003); 32: 490-493.
5. Clark RW, Sutfin TA, Ruggeri RB, Willauer AT, Sugarman ED, Magnus-Aryitey G, Cosgrove PG, Sand TM, Wester RT, Williams JA, Perlman ME, Bamberger MJ. Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: An initial multidose study of torcetrapib. Arterioscler Thromb Vasc Biol (2004); 24: 490-497.
6. Constans J, Marchand JM, Conri C, Peuchant E, Seigneur M, Rispal P, Lasseur C, Pellegrin JL, Leng B. Asymptomatic atherosclerosis in HIV-positive patients: A case-control ultrasound study. Ann Med (1995); 27: 683-685.
7. Crouse JR, III, Craven TE, Hagaman AP, Bond MG. Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery. Circulation (1995); 92: 1141-1147.
8. Currier JS. Cardiovascular risk associated with HIV therapy. JAIDS -Journal of Acquired Immune Deficiency Syndromes (2002); 31: S16-S23.
9. Currier JS, Kendall MA, Zackin R, Henry WK, Alston-Smith B, Torriani FJ, Schouten J, Mickelberg K, Li Y, Hodis HN. Carotid artery intima-media thickness and HIV infection: Traditional risk factors overshadow impact of protease inhibitor exposure. AIDS (2005); 19: 927-933.
10. Dube MP, Sattler FR. Metabolic complications of antiretroviral therapies. AIDS Clin Care (1998); 10: 41-44.
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA (2001); 285: 2486-2497.
12. Friis-Moller N, Sabin CA, Weber R, d'Arminlo Monforte A, El-Sadr WM, Reiss P, Thiebaut R, Morfeldt L, De Wit S, Pradier C, Calvo G, Law MG, Kirk O, Phillips AN, Lundgren JD. Combination antiretroviral therapy and the risk of myocardial infarction. New England Journal of Medicine (2003a); 349: 1993-2003.
13. Friis-Moller N, Weber R, Reiss P, Thiebaut R, Kirk O, Monforte AD, Pradier C, Morfeldt L, Mateu S, Law M, El-Sadr W, De Wit S, Sabin CA, Phillips AN, Lundgren JD. Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study. AIDS (2003b); 17: 1179-1193.
14. Grunfeld C, Kotler DP, Shigenaga JK, Doerrler W, Tierney A, Wang J, Pierson RN, Jr, Feingold KR. Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med (1991); 90: 154-162.
15. Henry K, Melroe H, Huebesch J, Hermundson J, Simpson J. Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities. Lancet (1998); 352: 1031-1032.
16. Holmberg SD, Moorman AC, Williamson JM, Tong TC, Ward DJ, Wood KC, Greenberg AE, Janssen RS. Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet (2002); 360: 1747-1748.
17. Howard G, Sharrett AR, Heiss G, Evans GW, Chambless LE, Riley WA, Burke GL. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke (1993); 24: 1297-1304.
18. Hsue PY, Lo JC, Franklin A, Bolger AF, Martin JN, Deeks SG, Waters DD. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation (2004); 109: 1603-1608.
19. Kablak-Ziembicka A, Tracz W, Przewlocki T, Pieniazek P, Sokolowski A, Konieczynska M. Association of increased carotid intima-media thickness with the extent of coronary artery disease. Heart (2004); 90: 1286-1290.
20. van Leth F, Phanuphak P, Stroes E, Gazzard B, Cahn P, Raffi F, Wood R, Bloch M, Katlama C, Kastelein JJP, Schechter M, Murphy RL, Horban A, Hall DB, Lange JMA, Reiss P. Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1. Plos Med (2004); 1: 64-74.
21. Maggi P, Lillo A, Perilli F, Maserati R, Chirianni A. Colour-Doppler ultrasonography of carotid vessels in patients treated with antiretroviral therapy: A comparative study. AIDS (2004); 18: 1023-1028.
22. Mary-Krause M, Cotteb L, Simon A, Partisani M, Costagliola D. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS (2003); 17: 2479-2486.
23. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK, Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med (1999); 340: 14-22.
24. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med (1998); 338: 853-860.
25. Riddler SA, Smit E, Cole SR, Li R, Chmiel JS, Dobs A, Palella F, Visscher B, Evans R, Kingsley LA. Impact of HIV infection and HAART on serum lipids in men. JAMA (2003); 289: 2978-2982.
26. Seminari E, Pan A, Voltini G, Carnevale G, Maserati R, Minoli L, Meneghetti G, Tinelli C, Testa S. Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors. Atherosclerosis (2002); 162: 433-438.
27. SoRelle R. Vascular and lipid syndromes in selected HIV-infected patients. Circulation (1998); 98: 829-830.
28. Tabib A, Greenland T, Mercier I, Loire R, Mornex JF. Coronary lesions in young HIV-positive subjects at necropsy. Lancet (1992); 340: 730.
29. Thiebaut F, Aurillac-Lavignolle V, Bonnet F, Ibrahim N, Cipriano C, Neau D, Dupon M, Dabis FO, Mercie P. Change in atherosclerosis progression in HIV infected patients: ANRS Aquitaine cohort, 1999-2004. AIDS (2005); 19: 729-731.